Skip to content

SYNGULON

Open bankruptcy
Public limited companyfounded 2013Rue du Bois St-Jean 15/1, 4102 Seraing, BelgiumKBO/BCE: BE 0521.816.349

A bankruptcy procedure is open for SYNGULON according to publications in the Belgian State Gazette; curator: FRANCOIS MINON.

Summary

The 2023 annual accounts show equity of €2.52M and a net result of €-721k.

Signals

Three signals. The signal on the left, the evidence on the right.
+raises riskneutral
raises risk · Register: open bankruptcy
The KBO register records the legal situation: open bankruptcy. This is today's state according to the register itself; the register carries no start date.
KBO · legal situation
raises risk · Open bankruptcy
Active bankruptcy procedure in the Belgisch Staatsblad. Claims are handled by the appointed curator.
Belgian State Gazette
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2023 was due by 31-07-2024 and was filed on 19-07-2024, 12 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
not confirmed
2024
not filed
2023
12 d early
2022
17 d early
2021
27 d early
2020
16 d early
2019
32 d early
← before the deadline after the deadline →
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2023, full schema

Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€-721k▲ 27.7%
2022 · €-997k
2018: €-695k 2019: €809k 2020: €-869k 2021: €-718k 2022: €-997k
2018 → 2023
Working capital
€89k
2022 · €-146k
2018: €678k 2019: €559k 2020: €102k 2021: €853k 2022: €-146k
2018 → 2023
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20192020202120222023Trend
Equity€4.23M-€3.36M▼ 20.5%€3.18M▼ 5.4%€2.45M▼ 23.2%€2.52M▲ 3.2%
Operating result€829k-€-841k€-675k▲ 19.7%€-945k▼ 40.0%€-676k▲ 28.5%
Net result€809k-€-869k€-718k▲ 17.4%€-997k▼ 38.8%€-721k▲ 27.7%
Result per fiscal year
Operating resultNet result
€-1.00M€-500k€0€500k€1.00MOperating result 2019: €829k€829kNet result 2019: €809k€809kOperating result 2020: €-841k€-841kNet result 2020: €-869k€-869kOperating result 2021: €-675k€-675kNet result 2021: €-718k€-718kOperating result 2022: €-945k€-945kNet result 2022: €-997k€-997kOperating result 2023: €-676k€-676kNet result 2023: €-721k€-721k20192020202120222023€-1M€-750k€-500k€-250k€0Operating result 2021: €-675k€-675kNet result 2021: €-718k€-718kOperating result 2022: €-945k€-945kNet result 2022: €-997k€-997kOperating result 2023: €-676k€-676kNet result 2023: €-721k€-721k202120222023
The operating result stays negative: a loss of €676k in 2023 against €945k in 2022; the loss shrinks.
Balance-sheet composition
2023 in colour, 2022 as the grey bar beneath
Assets €5.66M
Fixed assets €4.30M ▼ 2.3%
Current assets €1.36M ▲ 22.8%
Equity and liabilities €5.66M
Equity €2.52M ▲ 3.2%
Debt €3.13M ▲ 2.3%
Debt's share of the balance-sheet total falls from 55.6% to 55.4%. Equity and debt are higher.
Key figures and ratios
2023 value · change against 2022
EBITDA
€-576k
2022 · €-844k
Cash flow
€-620k
2022 · €-895k
Current ratio
1.07
2022 · 0.88
Debt to equity
1.24
2022 · 1.25
ROE
-28.5%
2022 · -40.8%
ROA
-12.7%
2022 · -18.1%
Interest coverage
-12.89
2022 · -16.46
Debt ≤ 1 year
€1.27M
2022 · €1.25M
Debt > 1 year
€628k
2022 · €723k
Staff costs
€711k
2022 · €822k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2023 against 2022 · 50 lines
Balance sheet Code20222023
Assets
Total assets20/58€5.51M€5.66M
Fixed assets21/28€4.40M€4.30M
Intangible fixed assets21€4.40M€4.30M
Tangible fixed assets22/27€1k€621
Plant, machinery and equipment23€1k€621
Financial fixed assets28€50€50=
Current assets29/58€1.11M€1.36M
Amounts receivable within one year40/41€1.09M€1.29M
Trade receivables40€39k€23k
Other amounts receivable41€1.05M€1.27M
Cash at bank and in hand54/58€1k€11k
Deferred charges and accrued income490/1€15k€56k
Equity and liabilities
Total equity and liabilities10/49€5.51M€5.66M
Equity10/15€2.45M€2.52M
Contributions10/11€4.20M€3.25M
Capital10€4.20M€3.25M
Issued capital100€4.20M€3.25M
Profit (loss) carried forward14€-1.75M€-721k
Amounts payable17/49€3.06M€3.13M
Amounts payable after more than one year17€723k€628k
Financial debts170/4€593k€465k
Other amounts payable178/9€130k€163k
Amounts payable within one year42/48€1.25M€1.27M
Current portion of amounts payable after more than one year42€118k€127k
Financial debts43€538k€554k
Credit institutions430/8€538k€554k
Trade debts44€282k€428k
Suppliers440/4€282k€428k
Taxes, remuneration and social security45€214k€160k
Taxes450/3€19k€20k
Remuneration and social security454/9€195k€139k
Other amounts payable47/48€100k€0
Accrued charges and deferred income492/3€1.09M€1.24M
Income statement Code20222023
Non-recurring operating income76A€34k€0
Remuneration, social security and pensions62€822k€711k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€101k€101k
Other operating charges640/8€15k€8k
Gross operating margin9900€-7k€143k
Operating profit (loss)9901€-945k€-676k
Financial income75/76B€1€1
Recurring financial income75€1€1
Financial charges65/66B€51k€45k
Recurring financial charges65€51k€45k
Profit (loss) for the period before taxes9903€-997k€-721k
Profit (loss) for the period9904€-997k€-721k
Profit (loss) for the period to be appropriated9905€-997k€-721k
Appropriation of the result
Profit (loss) to be appropriated9906€-1.75M€-2.47M
Profit (loss) brought forward from the previous period14P€-754k€-1.75M
Transfer from equity791/2€0€1.75M
Social balance
Average headcount (FTE)908710.29.0

The notes to these accounts (20 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

2025
28-02
Bankruptcy Opening
Tribunal de l’entreprise de Liège, division Liège · SYNGULON SA RUE DU BOIS ST-JEAN 15/1, 4102 OUGREE · event 24-02-2025
2024
19-07
NBB filing Annual accounts filed
fiscal year 2023 · full schema
2023
14-07
NBB filing Annual accounts filed
fiscal year 2022 · full schema
2022
31-12
Financial Weakest financial yearnet €-997k
Net result drops to €-997k, the lowest in the series.
04-07
NBB filing Annual accounts filed
fiscal year 2021 · full schema
2021
15-07
NBB filing Annual accounts filed
fiscal year 2020 · full schema
2020
29-06
NBB filing Annual accounts filed
fiscal year 2019 · full schema
2019
31-12
Financial Back to profitnet €809k
Net result €809k after one loss-making year.
08-07
NBB filing Annual accounts filed
fiscal year 2018 · full schema
2018
03-07
NBB filing Annual accounts filed
fiscal year 2017 · full schema
2017
30-06
NBB filing Annual accounts filed
fiscal year 2016 · full schema
2016
05-07
NBB filing Annual accounts filed
fiscal year 2015 · full schema
2015
05-08
NBB filing Annual accounts filed
fiscal year 2014 · full schema · 5 days late
SignalFinancial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
15 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Seraing · 1 establishment unit since 2013
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Rue du Bois St-Jean 15/14102 Seraing
1 establishment unit
SYNGULON
Rue du Bois St-Jean 15/1, 4102 SeraingResearch and development on biotechnology
since 20132.220.793.125

Insolvency mandates

1 mandate
Role Name Tenure
Curator FRANCOIS MINON
RUE DES AUGUSTINS 32, 4000 LIEGE 1
24-02-2025present

Public money · subsidies and aid

European research

2 projects
Programmes
Horizon 2020
1 entry
Horizon Europe
1 entry
Projects
Breaking the barrier - An integrated multidisciplinary approach to kill Gram-negative bacteria through existing antibiotics by making their outer membrane permeable
Horizon Europe · associated partner · 01-01-2023 to 30-09-2027 · BREAKthrough
The Algal Microbiome: Friends and Foes
Horizon 2020 · partner · 01-01-2015 to 31-12-2018 · ALFF

Similar companies · same sector, comparable size

Of 761 companies in sector 72101 we hold annual accounts for 481. 246 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Company data · Crossroads Bank

Identification
Legal formPublic limited company
Founded07-03-2013
Fiscal year end31-12
Activities, NACEBEL 2025
72101Research and development on biotechnology
Sources
Crossroads Bank for EnterprisesNational Bank · 10 filings

Scores and ratios are computed by Checked and are not a credit decision.